Literature DB >> 9521498

Nodular post-kala-azar dermal leishmaniasis: a distinct histopathological entity.

N Singh1, V Ramesh, V K Arora, A Bhatia, A Kubba, M Ramam.   

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) is an infrequently occurring sequel to treated visceral leishmaniasis. Diagnosis, particularly in non-endemic areas, is difficult because the clinical appearances may be subtle and simulate lepromatous leprosy. The histopathology of the condition has been a neglected subject. Nodular lesions constitute one of the large variety of lesions that can be seen in PKDL. This paper describes the histopathology of such lesions in 26 patients seen over a period of approximately 8 years in a non-endemic setting. All the biopsies had strikingly similar light microscopic features with characteristic findings: a dense lymphohistiocytic infiltrate beneath an atrophic epidermis, pronounced follicular plugging, vascular hyalinization and collagen changes and negative Fite stain. These allow a definite diagnosis of PKDL even in the absence of demonstrable Leishman-Donovan (L-D) bodies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521498     DOI: 10.1111/j.1600-0560.1998.tb01696.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Splenectomy in Patients with Visceral Leishmaniasis Resistant to Conventional Therapy and Secondary Prophylaxis: A Retrospective Cohort.

Authors:  Luis G C Reinaldo; Raimundo J C Araújo-Júnior; Thiago M Diniz; Rafael D Moura; Antônio J Meneses-Filho; Caio V V M Furtado; Washington L C Santos; Dorcas L Costa; Kelsen D Eulálio; Gabriel R Ferreira; Carlos H N Costa
Journal:  Am J Trop Med Hyg       Date:  2022-06-20       Impact factor: 3.707

2.  Histopathology of Post Kala-azar Dermal Leishmaniasis.

Authors:  V Ramesh; M Ramam
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

3.  Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis.

Authors:  Piyush Kumar; Mitali Chatterjee; Nilay Kanti Das
Journal:  Indian J Dermatol       Date:  2021 Jan-Feb       Impact factor: 1.494

4.  Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.

Authors:  V Ramesh; Ruchi Singh; Kumar Avishek; Aditya Verma; Deepak Kumar Deep; Sandeep Verma; Poonam Salotra
Journal:  PLoS Negl Trop Dis       Date:  2015-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.